Cover Image

REGENERATIVE ENDODONTICS AND STEM CELL THERAPY

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Authors:	Patel, Ronak N, Desai, Dhaval, Rawal, Aabha, Thakkar, Jaini
Format:	Recurso digital
Language:	English
Published:	Zenodo 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

APPLICATION OF ULTRASONIC SYSTEMS IN ENDODONTICS
by: Arkhmammadova, Gulshan Mubariz, et al.
Published: (2025)

Financial Literacy in Rural Areas of Satara District
by: Aabha Gotkhindikar
Published: (2026)

India y Pakist n. Las medidas necesarias de creación de confianza / Aabha Dixit
by: Dixit, Aabha
Published: (1996)

EMBRYONIC AND REGENERATIVE DEVELOPMENT IN PLANARIANS
by: Bardeen, Charles Russell
Published: (1902)

351 | FINAL SAFETY ANALYSIS IN PARTICIPANTS WITH HEMATOLOGIC MALIGNANCIES WHO RECEIVED ALLOGENEIC STEM CELL TRANSPLANT AFTER PEMBROLIZUMAB THERAPY
by: J. Kuruvilla, et al.
Published: (2025)

449 | BRIDGING TO CAR‐T CELL THERAPY IN LARGE B‐CELL LYMPHOMA WITH EITHER CONVENTIONAL THERAPY OR THE CD3xCD20 BISPECIFIC ANTIBODY GLOFITAMAB
by: J. K. Schleifenbaum, et al.
Published: (2025)

16 | EPIGENETIC MECHANISMS AND THERAPY FOR B‐CELL LYMPHOMAS
by: A. M. Melnick
Published: (2025)

657 | TRANSPLANTATION IN COMBINATION WITH CAR‐T THERAPY FOR REFRACTORY/RELAPSED AGGRESSIVE B‐CELL LYMPHOMA AFTER FAILURE OF CD19 CAR‐T CELL THERAPY
by: F. Yang, et al.
Published: (2025)

407 | RADIATION THERAPY FOR OLIGO‐RELAPSED/PROGRESSIVE DISEASE POST‐STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA: FACTORS ASSOCIATED WITH FAVORABLE OUTCOMES
by: B. Fregonese, et al.
Published: (2025)

714 | CART CELL THERAPY IN THE MANAGEMENT OF SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
by: N. K. Dave, et al.
Published: (2025)

Impact of Monomer Selection and Behavior on Transdermal Drug Delivery Systems: Regulatory and Formulation Perspectives
by: Piyush, Modi, et al.
Published: (2026)

453 | EFFICACY AND TOXICITY OF RADIATION THERAPY PRIOR TO CHIMERIC ANTIGEN RECEPTOR T‐CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
by: K. Daniels, et al.
Published: (2025)

276 | MODERN TRENDS AND OUTCOMES OF THE INCREASING UTILIZATION OF RADIATION THERAPY IN MANTLE CELL LYMPHOMA
by: A. Deshane, et al.
Published: (2025)

REGENERATIVE AGRICULTURE AND THE PROBLEM OF SUSTAINABILITY. CONTRIBUTIONS FOR A DISCUSSION
by: Ismael Pablo Ibarra Vrska
Published: (2019)

SPIN: Structural LLM Planning via Iterative Navigation for Industrial Tasks
by: Ozaki, Yusuke, et al.
Published: (2026)

MCP-Cosmos: World Model-Augmented Agents for Complex Task Execution in MCP Environments
by: Ganapavarapu, Giridhar, et al.
Published: (2026)

Towards Autonomous Navigation of Neuroendovascular Tools for Timely Stroke Treatment via Contact-aware Path Planning
by: Tamhankar, Aabha, et al.
Published: (2025)

601 | TARGETING NAMPT AND BTK IN MANTLE CELL LYMPHOMA: TP53‐DEPENDENT SYNERGISTIC THERAPY
by: Y. Liu, et al.
Published: (2025)

758 | CLINICAL OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HEPATOSPLENIC T‐CELL LYMPHOMA
by: Z. Zhang, et al.
Published: (2025)

336 | CAR T‐CELL THERAPY IS HIGHLY EFFECTIVE IN VITREORETINAL LYMPHOMAS. A LOC NETWORK STUDY
by: S. Choquet, et al.
Published: (2025)

413 | PROGRESSION PATTERNS BY POSITRON EMISSION TOMOGRAPHY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER CAR T CELL THERAPY: POTENTIAL ROLE FOR RADIOTHERAPY?
by: A. D. Dreyfuss, et al.
Published: (2025)

462 | OUTCOMES AFTER CAR‐T CELL THERAPY (TISAGENLECLEUCEL OR AXICABTAGENE CILOLEUCEL) IN PATIENTS OLDER THAN 70 YEARS WITH DIFFUSE LARGE B CELL LYMPHOMA
by: V. Rocha, et al.
Published: (2025)

654 | PREDICTIVE VALUE OF EXTRANODAL INVOLVEMENT ON CLINICAL OUTCOMES AND TOXICITIES IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA FOLLOWING CAR‐T CELL THERAPY
by: S. Belbachir, et al.
Published: (2025)

785 | HEMATOLOGIC TOXICITY ANALYSIS OF CAR‐T CELL THERAPY: A RETROSPECTIVE REAL‐WORLD STUDY
by: H. Wang, et al.
Published: (2025)

798 | PROTEOLYSIS‐TARGETING CHIMERA TARGETING BTK DEGRADATION FOR CANCER THERAPY IN MANTLE CELL LYMPHOMA
by: X. Wang, et al.
Published: (2025)

848 | A PILOT STUDY OF EMAPALUMAB FOR THE TREATMENT OF CAR T‐CELL THERAPY‐ASSOCIATED PROLONGED CYTOPENIA
by: Z. E. Hunzeker, et al.
Published: (2025)

313 | DOUBLE REFRACTORY STATUS CONFIRMS INFERIOR SURVIVAL IN LARGE B‐CELL LYMPHOMA ELIGIBLE FOR THIRD‐LINE CD19 CHIMERIC ANTIGEN T‐CELL THERAPY
by: C. Abeyakoon, et al.
Published: (2025)

Semileptonic decay and form factors of $Ω_b^- \rightarrow Ω_c^0\,e\,\bar{ν_e}$
by: Patel, Kinjal, et al.
Published: (2025)

Electromagnetic and weak decay of singly Heavy Baryons (Qqq)
by: Patel, Kinjal, et al.
Published: (2025)

Transition properties of Doubly Heavy Baryons
by: Patel, Kinjal, et al.
Published: (2024)

Semileptonic decay form factors of $Ξ_b^0 \rightarrow Ξ_c^+\ell\barν_{\ell}$ in HQET
by: Patel, Kinjal, et al.
Published: (2026)

467 | SAFETY AND EFFICACY OF FT522, AN OFF‐THE‐SHELF, IPSC‐DERIVED CD19 CAR NK CELL THERAPY WITH ALLOIMMUNE DEFENSE RECEPTOR IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA
by: V. Bachanova, et al.
Published: (2025)

457 | BREATH BIOMARKERS FOR PREDICTION OF CYTOKINE RELEASE SYNDROME IN PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T‐CELL THERAPY
by: T. M. John, et al.
Published: (2025)

112 | PHASE I STUDY OF SPLIT‐COURSE BRIDGING RADIOTHERAPY (SC‐BRT) PRIOR TO CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY B‐CELL LYMPHOMAS
by: B. S. Imber, et al.
Published: (2025)

409 | EARLY IDENTIFICATION OF CAR T‐CELL THERAPY NON‐RESPONDERS IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA USING FDG‐PET QUANTITATIVE PARAMETERS
by: C. Pellegrini, et al.
Published: (2025)

463 | ANTI‐CD19 CAR‐T CELL THERAPY IN RELAPSED/REFRACTORY T‐CELL/HISTIOCYTE‐RICH LARGE B‐CELL LYMPHOMA: INSIGHTS FROM THE FRENCH DESCAR‐T REGISTRY, A LYSA STUDY
by: A. André, et al.
Published: (2025)

ADVANCEMENTS IN HEART FAILURE MANAGEMENT: FROM NEUROHORMONAL MODULATION TO EMERGING REGENERATIVE THERAPIES
by: Shermatov Bektosh Bayon o'g'li, et al.
Published: (2025)

THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM?
by: Kubrusly , Fernando Bermudez, et al.
Published: (2024)

Towards Building General Purpose Embedding Models for Industry 4.0 Agents
by: Constantinides, Christodoulos, et al.
Published: (2025)

Fine-Tuned Thoughts: Leveraging Chain-of-Thought Reasoning for Industrial Asset Health Monitoring
by: Lin, Shuxin, et al.
Published: (2025)